Agency Forms Undergoing Paperwork Reduction Act Review, 12361-12362 [2023-03959]

Download as PDF 12361 Federal Register / Vol. 88, No. 38 / Monday, February 27, 2023 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Form name Public Health Laboratories ................... 3b. Annual Evaluation and Performance Measurement Report for Bacterial Specimen Testing. 3c. Monthly Data Report Form for Bacterial Specimen Testing. 3d. AR Lab Network Alerts—Bacterial Specimen Testing. 3e. Annual Evaluation and Performance Measurement Report (Candida identification). 3f. Monthly Data Report Form for Candida identification. 3g. AR Lab Network Alerts Report Form for Candida auris. 3h. Annual Evaluation and Performance Measurement Report (Neisseria gonorrhoeae). 3i. AR Lab Network Alert and Monthly Data Report Form for Neisseria gonorrhoeae. 3j. Annual Evaluation and Performance Measurement Report (C. auris Whole Genome Sequencing). 3k. AR Lab Network Form for Isolate/Specimenlevel Mycotics Testing (C. auris Whole Genome Sequencing). 3l. AR Lab Network Form for Phylogenetic Treelevel Mycotics Reporting (C. auris Whole Genome Sequencing). Public Health Laboratories ................... Public Health Laboratories ................... Public Health Laboratories ................... Public Health Laboratories ................... Public Health Laboratories ................... Public Health Laboratories ................... Public Health Laboratories ................... Public Health Laboratories ................... Public Health Laboratories ................... Public Health Laboratories ................... Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2023–03960 Filed 2–24–23; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–23–22FS] Agency Forms Undergoing Paperwork Reduction Act Review ddrumheller on DSK120RN23PROD with NOTICES Number of respondents Type of respondents In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled ‘‘Artificial Stone Countertops: Exposures, Controls, Surveillance, & Translation’’ to the Office of Management and Budget (OMB) for review and approval. CDC previously published a ‘‘Proposed Data Collection Submitted for Public Comment and Recommendations’’ notice on June 02, 2022 to obtain comments from the public and affected agencies. CDC did not receive comments related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments. VerDate Sep<11>2014 20:06 Feb 24, 2023 Jkt 259001 CDC will accept all comments for this proposed information collection project. The Office of Management and Budget is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570. Comments and recommendations for the proposed information collection should be sent within 30 days of publication of PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 Average number of responses per respondent Average burden per response (in hours) 56 1 4 56 12 4 56 34 6/60 56 1 2 56 12 2 56 13 6/60 56 1 1 56 12 6/60 56 1 1 56 12 6/60 56 12 6/60 this notice to www.reginfo.gov/public/ do/PRAMain Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 395–5806. Provide written comments within 30 days of notice publication. Proposed Project Artificial Stone Countertops: Exposures, Controls, Surveillance, & Translation—New—National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC). Background and Brief Description As a recently introduced technology in the United States, the Artificial Stone (AS) Countertop industry is not well defined; the obligation to monitor workers’ health might not be known, considered, or understood; and education on potential hazard and health risks related to respirable crystalline silica (RCS) is limited. Exposure is associated with the development of silicosis, an irreversible, sometimes fatal, but preventable lung disease. Twenty-four cases of silicosis, E:\FR\FM\27FEN1.SGM 27FEN1 12362 Federal Register / Vol. 88, No. 38 / Monday, February 27, 2023 / Notices including two deaths, have been reported among AS fabrication workers in the United States. The anticipated impacts of this project are increased understanding of industry scale, practices, and medical monitoring, and increased collaboration and communication to inform the AS Countertop industry of industry hazards, methods to mitigate exposure, and improve medical surveillance. Understanding how or if current RCS recommendations and regulations are used by various AS Countertop fabrication facilities will identify approaches for improved intervention. The purpose of the proposed collection is to conduct a survey with AS Countertop fabrication facilities to better understand: (1) work practices and controls related to respirable crystalline silica; (2) barriers or facilitators to implementation of medical and exposure monitoring requirements; (3) identify areas for potential intervention; and (4) identify countertop fabrication facilities willing to participate in future NIOSH exposure and health research. The estimate of burden hours is based on an internal pilot test of the survey instrument. The average time for reviewing instructions, gathering mock information, and completing the survey was between 10–30 minutes. For the purposes of estimating burden hours, the median time to complete the survey is used. An estimated 8,600 respondents are anticipated to participate in the survey. for 2,150 annual burden hours. There are no costs to respondents other than their time to participate. ESTIMATED ANNUALIZED BURDEN HOURS Form name Facility Managers/Owners .............................. Workplace Survey .......................................... Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2023–03959 Filed 2–24–23; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–23–22HY] Agency Forms Undergoing Paperwork Reduction Act Review ddrumheller on DSK120RN23PROD with NOTICES Number of respondents Type of respondents In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) has submitted the information collection request titled, ‘‘Centralized Institutional Review for the CDC Expanded Access Investigational New Device (EA–IND) for Use of Tecovirimat (TPOXX®) for Treatment of Human Non-Variola Orthopoxvirus Infections in Adults and Children (IND 116039/CDC #6402),’’ to the Office of Management and Budget (OMB) for review and approval. CDC previously published a ‘‘Proposed Data Collection Submitted for Public Comment and Recommendations’’ notice on August 22, 2022, to obtain comments from the public and affected agencies. CDC received two comments related to the previous notice. This notice serves to allow an additional 30 days for public and affected agency comments. CDC will accept all comments for this proposed information collection project. The Office of Management and Budget VerDate Sep<11>2014 20:06 Feb 24, 2023 Jkt 259001 is particularly interested in comments that: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including, through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570. Comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/ do/PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 8,600 Number of responses per respondent 1 Average burden per response (in hours) 15/60 Street NW, Washington, DC 20503 or by fax to (202) 395–5806. Provide written comments within 30 days of notice publication. Proposed Project Centralized Institutional Review for the CDC Expanded Access Investigational New Device (EA–IND) for ‘‘Use of Tecovirimat (TPOXX®) for Treatment of Human Non-Variola Orthopoxvirus Infections in Adults and Children’’ (IND 116039/CDC #6402)— New—Office of Science (OS), Centers for Disease Control and Prevention (CDC). Background and Brief Description Monkeypox is a zoonosis, caused by the Orthopoxvirus (OPXV) Monkeypox virus (MPXV), and is endemic to forested areas of West and Central Africa. In humans, infection with MPXV can lead to a smallpox-like illness with fatal outcomes in up to 11% of patients without prior smallpox vaccination. Since May 2022, clusters of monkeypox cases, have been reported in 19 countries that do not normally have monkeypox, and the number of confirmed cases in the U.S. is rapidly increasing. Tecovirimat (TPOXX) is FDAapproved for the treatment of human smallpox disease caused by Variola virus in adults and children. However, its use for other orthopoxvirus infections, including monkeypox, is not approved by the FDA. CDC currently holds a non-research expanded access Investigational New Drug (EA–IND) protocol that allows for the use of tecovirimat for primary or early empiric treatment of non-variola orthopoxvirus E:\FR\FM\27FEN1.SGM 27FEN1

Agencies

[Federal Register Volume 88, Number 38 (Monday, February 27, 2023)]
[Notices]
[Pages 12361-12362]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-03959]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-23-22FS]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Artificial Stone Countertops: Exposures, 
Controls, Surveillance, & Translation'' to the Office of Management and 
Budget (OMB) for review and approval. CDC previously published a 
``Proposed Data Collection Submitted for Public Comment and 
Recommendations'' notice on June 02, 2022 to obtain comments from the 
public and affected agencies. CDC did not receive comments related to 
the previous notice. This notice serves to allow an additional 30 days 
for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Artificial Stone Countertops: Exposures, Controls, Surveillance, & 
Translation--New--National Institute for Occupational Safety and Health 
(NIOSH), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    As a recently introduced technology in the United States, the 
Artificial Stone (AS) Countertop industry is not well defined; the 
obligation to monitor workers' health might not be known, considered, 
or understood; and education on potential hazard and health risks 
related to respirable crystalline silica (RCS) is limited. Exposure is 
associated with the development of silicosis, an irreversible, 
sometimes fatal, but preventable lung disease. Twenty-four cases of 
silicosis,

[[Page 12362]]

including two deaths, have been reported among AS fabrication workers 
in the United States. The anticipated impacts of this project are 
increased understanding of industry scale, practices, and medical 
monitoring, and increased collaboration and communication to inform the 
AS Countertop industry of industry hazards, methods to mitigate 
exposure, and improve medical surveillance. Understanding how or if 
current RCS recommendations and regulations are used by various AS 
Countertop fabrication facilities will identify approaches for improved 
intervention.
    The purpose of the proposed collection is to conduct a survey with 
AS Countertop fabrication facilities to better understand: (1) work 
practices and controls related to respirable crystalline silica; (2) 
barriers or facilitators to implementation of medical and exposure 
monitoring requirements; (3) identify areas for potential intervention; 
and (4) identify countertop fabrication facilities willing to 
participate in future NIOSH exposure and health research.
    The estimate of burden hours is based on an internal pilot test of 
the survey instrument. The average time for reviewing instructions, 
gathering mock information, and completing the survey was between 10-30 
minutes. For the purposes of estimating burden hours, the median time 
to complete the survey is used. An estimated 8,600 respondents are 
anticipated to participate in the survey. for 2,150 annual burden 
hours. There are no costs to respondents other than their time to 
participate.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Facility Managers/Owners..............  Workplace Survey........           8,600               1           15/60
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2023-03959 Filed 2-24-23; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.